晚期卵巢癌肿瘤细胞减灭术中肠道造口后的生存率与还纳机会:一项基于人群的队列研究
造口与死亡风险增加相关仅见于单因素分析(HR 1.30),校正后无显著关联。暂时性造口2年内还纳概率为48%,中位还纳时间10个月,高手术复杂性评分与还纳几率增加相关(OR 3.43)。
要点
- 晚期卵巢癌肿瘤细胞减灭术中肠道造口不似乎影响预后。
- 暂时性造口2年内还纳概率为48%,中位还纳时间10个月。
- 高手术复杂性评分与造口还纳几率增加相关(OR 3.43)。
核心结论
- 肠道造口形成似乎不影响晚期上皮性卵巢癌女性的预后。
- 除高手术复杂性评分外,未能识别出肿瘤细胞减灭术时已知的可预测造口还纳几率的因素。
研究设计与样本
- 基于人群的队列研究,纳入2009至2018年瑞典斯德哥尔摩/哥特兰地区所有诊断为晚期上皮性卵巢癌的女性888例,均行肿瘤细胞减灭术。
- 采用比例风险回归分析造口与生存的关联,以死亡或复发为竞争风险采用累积发生率函数估计造口还纳概率,采用逻辑回归分析临床因素与还纳的关联。
主要发现
- 单因素分析中造口与死亡风险增加相关(HR 1.30,95%CI 1.05-1.61;p=0.02),校正分析中无显著关联。
- 暂时性造口2年内还纳概率为48%(95%CI 38-58),中位还纳时间为10个月。
- 高手术复杂性评分与还纳几率增加相关(OR 3.43,95%CI 1.06-11.05;p=0.04)。
关键数值与推荐
- 造口与死亡风险的单因素分析HR 1.30(95%CI 1.05-1.61;p=0.02),校正后无显著关联。
- 暂时性造口2年内还纳概率48%(95%CI 38-58)。
- 高手术复杂性评分与还纳的OR 3.43(95%CI 1.06-11.05;p=0.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our objective was to examine oncologic outcome in women with advanced epithelial ovarian cancer (aEOC) receiving an intestinal stoma (IS) at the time of cytoreductive surgery (CRS), probability of stoma reversal (SR) and variables affecting odds of SR. METHODS: This population-based cohort study included all women diagnosed with aEOC between 2009 and 2018 in the Stockholm/Gotland Region of Sweden. The association between IS formation at CRS and survival was analyzed with proportional hazards regression yielding hazard ratios (HR) with 95% confidence intervals (CI), adjusted for predefined confounders. Cumulative incidence functions, with death or recurrence as competing risk, were used to estimate chance of SR. The association between clinical factors and SR was analyzed with logistic regression yielding odds ratios (OR) with 95% CI. RESULTS: The final analysis included 888 women undergoing CRS for aEOC. Of these, 129 (14,5%) received an IS of which 74% (n = 95) were defunctioning and 26% (n = 34) permanent. IS was associated with an increased hazard of death (HR 1.30, CI 95%, 1.05-1.61; p = 0.02) in the univariate analysis, however not in the adjusted analysis. The probability of SR of defunctioning IS within 2 years was 48% (95% CI, 38-58). Median time to SR was 10 months. High surgical complexity score (SCS) was associated with increased odds of reversal (OR 3.43, 95% CI, 1.06-11.05; p = 0.04). CONCLUSIONS: IS formation does not seem to affect prognosis in women with aEOC. We could not identify any factor, known at time of CRS, that may predict the odds of SR except a high SCS.
引用
- Kofoed NG, Falconer H, Vanky H, et al. Survival and chance of reversal after intestinal stoma formation during cytoreductive surgery for advanced ovarian cancer; a population-based cohort study. Gynecol Oncol. 2023. PMID: 36738484. doi:10.1016/j.ygyno.2023.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。